New Developments in Neuromyelitis Optica Spectrum Disorder: Expert Guidance on Diagnosis, Treatment Strategies, and the Patient Perspective

New Developments in Neuromyelitis Optica Spectrum Disorder: Expert Guidance on Diagnosis, Treatment Strategies, and the Patient Perspective is organized by Med Learning Group.

Release Date: June 08, 2022
Expiration Date: June 08, 2023

Program Overview:
This enduring activity will cover the treatment of patients with neuromyelitis optica spectrum disorder (NMOSD).

Learning Objectives:
After completing in this educational initiative, clinicians should be better able to:
• Establish a diagnosis of NMOSD by using guideline-based and clinical criteria and differentiating it from other autoimmune disorders
• Compare and contrast the mechanisms of action, efficacy, safety, and tolerability of FDA-approved agents for NMOSD
• Leverage the patient’s symptoms, quality of life, comorbidities, and other factors to select NMOSD treatment for the best possible individualized outcomes